CAFs-derived exosomes deliver circZFR into HCC, inhibit the STAT3/NF-κB pathway, enhance cisplatin resistance, and promote the tumor progression (Kudo et al., 2018). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.